Research map: Radiocopper in BCMA-targeted immunotheranostics of myeloma
Back to the article
Papers in this map
Radiotherapy in the management of plasma cell tumors. · Kenneth Shung Hu · 2000 · 120 citations · Cited by this paper
Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment
· 2026 · Related
Surface-cleaned black phosphorus nanosheets chelate iron and rebalance the ferroptosis-immune axis in acute kidney injury
· 2026 · Related
Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways
· 2026 · Related
Inhibition of SRC prevents bone metastasis of breast cancer by blocking metastatic cell motility and bone directionality
· 2026 · Related
Magnetic hyperthermia as an intracellular immunomodulatory technology: From heat transduction to tumor immune reprogramming
· 2026 · Related
Ultra-high-field magnetic resonance imaging reveals sex-specific recovery after ischemic stroke following treatment with three-dimensional human mesenchymal stem cell–derived extracellular vesicles
· 2026 · Related
Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applications
· 2026 · Related
Targeting microglial MyD88 reprograms injury-activated microglia and promotes spinal cord repair via TGF-β signaling and biomimetic nanodelivery
· 2026 · Related
miR-15a-5p outperforms anti-VEGF drug in ocular neovascularization by providing dual anti-angiogenic and neuroprotective effects
· 2026 · Related
Recent advances in targeting cyanine dyes: hierarchical targeting mechanisms and theranostic integration for multi-disease precision therapy
· 2026 · Related
Source: OpenAlex (CC0)